Lung Cancer: Lung Cancer III |

Barriers for Lung Cancer Screening in an Inner City Community Primary Care Center FREE TO VIEW

Jean Bustamante Alvarez, MD; Konstantinos Sdrimas, MD; Jessica Stempel, MD; Daniel Brito, MD
Author and Funding Information

Albert EInstein Medical Center, Philadelphia, PA

Copyright 2016, American College of Chest Physicians. All Rights Reserved.

Chest. 2016;150(4_S):718A. doi:10.1016/j.chest.2016.08.813
Text Size: A A A
Published online


SESSION TYPE: Original Investigation Poster

PRESENTED ON: Wednesday, October 26, 2016 at 01:30 PM - 02:30 PM

PURPOSE: Lung cancer remains the leading cause of cancer death worldwide. Recently the USPFTF launched guidelines for lung cancer screening with low dose computer tomography of the chest. However compliance with the guidelines in the community remains low. We tried to identify barriers for proper lung cancer screening in the primary care setting.

METHODS: Anonymous questioners were filled by the internal medicine residents in a community practice center with 20 questions regarding their knowledge and practices about current USPSTF guidelines on lung cancer screening. Results were analyzed per year of training.In parallel, a patient survey regarding awareness and personal preferences regarding lung cancer screening was conducted and 50 of the questionnaires were included in the analysis.

RESULTS: 36 residents were included in the survey at the community center clinic of AEMC. 15 were PGY1, 13 PGY2 and 8 PGY3. 73 % of PGY 1s were aware of proper lung cancer screening with low dose CT of the chest, compared to 84.6%and 87.5% of PGY 2 and 3 respectively. Only 31 % of the residents felt confident applying the proper screening criteria and 69% of them felt they are not doing a good job referring patients for screening. 28 % of the patient preferred not to know whether they have lung cancer and 10% raised concerns about cost and lack of insurance coverage regarding screening.

CONCLUSIONS: The implementation of established lung cancer screening guidelines in the community remains problematic. Despite the non-invasiveness of the screening modality a significant percentage of the population refrains from screening due to the grave prognosis. At the same time residents even at the final year of training failed to properly screen and identify eligible candidates.

CLINICAL IMPLICATIONS: Lung cancer screening is a new tool that needs to be embraced by health care provider as well as patients who are at risk of developing this disease. Given the stablished benefit of detecting lung cancer in early stages and the potential for curative treatment, it is imperative to stress the need for continuous medical education regarding this subject and to stablish institutional quality improvement measures to guarantee compliance with lung cancer screening guidelines.

DISCLOSURE: The following authors have nothing to disclose: Jean Bustamante Alvarez, Konstantinos Sdrimas, Jessica Stempel, Daniel Brito

No Product/Research Disclosure Information




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543